Dulaglutide · source year
10 selected, source-linked Dulaglutide records carrying a 2021 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
10 selected records.
3 represented types.
10 distinct public records.
Cited chronology
Regulatory
DailyMed lists Structured Product Labeling version 41 for the reviewed Dulaglutide label family with a published date of 2021-12-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Literature metadata
PubMed lists PMID 34861012 in The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians as Journal Article, with publication-date metadata of 2018-06-25 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Regulatory
DailyMed lists Structured Product Labeling version 40 for the reviewed Dulaglutide label family with a published date of 2021-10-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Regulatory
DailyMed lists Structured Product Labeling version 39 for the reviewed Dulaglutide label family with a published date of 2021-10-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Safety
FDA's dated enforcement report D-0773-2021 lists Class II and source status Terminated for Eli Lilly & Company. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations.
Literature metadata
PubMed lists PMID 34153270 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2021-06-18 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Regulatory
DailyMed lists Structured Product Labeling version 38 for the reviewed Dulaglutide label family with a published date of 2021-04-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.
Literature metadata
PubMed lists PMID 32141343 in Current medical research and opinion as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-03-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Literature metadata
PubMed lists PMID 30410215 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2018-09-11 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Regulatory
DailyMed lists Structured Product Labeling version 37 for the reviewed Dulaglutide label family with a published date of 2021-01-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.